Literature DB >> 12562155

Alternative therapies for traditional disease states: osteoarthritis.

Vincent Morelli1, Christopher Naquin, Victor Weaver.   

Abstract

Americans spend more on natural remedies for osteoarthritis than for any other medical condition. In treating osteoarthritis, glucosamine and chondroitin sulfate, two of the molecular building blocks found in articular cartilage, are the most commonly used alternative supplements. In randomized trials of variable quality, these compounds show efficacy in reducing symptoms, but neither has been shown to arrest progression of the disease or regenerate damaged cartilage. Although few clinical trials on S-adenosylmethionine exist, preliminary evidence indicates that it relieves pain to a degree similar to that of nonsteroidal anti-inflammatory drugs but with fewer side effects. Clinical trials of dimethyl sulfoxide offer conflicting results. Neither ginger nor cetyl myristoleate has proven clinical usefulness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562155

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  14 in total

1.  Manual labor metacarpophalangeal arthropathy in a truck driver: a case report.

Authors:  Peter C Emary
Journal:  J Chiropr Med       Date:  2010-10-08

2.  Hypertonic dextrose injections (prolotherapy) for knee osteoarthritis: results of a single-arm uncontrolled study with 1-year follow-up.

Authors:  David Rabago; Aleksandra Zgierska; Luke Fortney; Richard Kijowski; Marlon Mundt; Michael Ryan; Jessica Grettie; Jeffrey J Patterson
Journal:  J Altern Complement Med       Date:  2012-04       Impact factor: 2.579

Review 3.  Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus.

Authors:  Christopher S Cobb; Edzard Ernst
Journal:  Clin Rheumatol       Date:  2005-10-12       Impact factor: 2.980

4.  Demonstrating the effectiveness of Platelet Rich Plasma and Prolotherapy treatments in knee osteoarthritis.

Authors:  Cansın Medin Ceylan; Tugba Sahbaz; Basak Cigdem Karacay
Journal:  Ir J Med Sci       Date:  2022-09-27       Impact factor: 2.089

5.  Qualitative Assessment of Patients Receiving Prolotherapy for Knee Osteoarthritis in a Multimethod Study.

Authors:  David Rabago; Laura van Leuven; Lane Benes; Luke Fortney; Andrew Slattengren; Jessica Grettie; Marlon Mundt
Journal:  J Altern Complement Med       Date:  2016-09-07       Impact factor: 2.579

6.  Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial.

Authors:  David Rabago; Jeffrey J Patterson; Marlon Mundt; Richard Kijowski; Jessica Grettie; Neil A Segal; Aleksandra Zgierska
Journal:  Ann Fam Med       Date:  2013 May-Jun       Impact factor: 5.166

7.  Current nutraceuticals in the management of osteoarthritis: a review.

Authors:  Nahid Akhtar; Tariq M Haqqi
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-06       Impact factor: 5.346

8.  Glucosamine and chondroitin sulfate association increases tibial epiphyseal growth plate proliferation and bone formation in ovariectomized rats.

Authors:  Roberta Bastos Wolff
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

9.  Knowledge, attitude, and practice of primary health care physicians in the management of osteoarthritis in Al-Jouf province, Saudi Arabia.

Authors:  Al-Hazmi Ahmad Homoud
Journal:  Niger Med J       Date:  2012-10

10.  A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.

Authors:  James D Kean; David Camfield; Jerome Sarris; Marni Kras; Richard Silberstein; Andrew Scholey; Con Stough
Journal:  Nutr J       Date:  2013-07-16       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.